Dedong Li

发表

Structural basis of human ACE2 higher binding affinity to currently circulating Omicron SARS-CoV-2 sub-variants BA.2 and BA.1.1

Liang Wang, N. Huang, J. Qi, 2022, Cell.

Neutralization of recombinant RBD-subunit vaccine ZF2001-elicited antisera to SARS-CoV-2 variants including Delta

Qihui Wang, A. Zheng, Rong Zhang, 2021, bioRxiv.

Molecular Basis of Mink ACE2 Binding to SARS-CoV-2 and Its Mink-Derived Variants

Qihui Wang, J. Qi, A. Zheng, 2022, Journal of virology.

An engineered bispecific human monoclonal antibody against SARS-CoV-2

F. Gao, Guizhen Wu, Shuguang Tan, 2022, Nature Immunology.

Target-Based Virtual Screening and LC/MS-Guided Isolation Procedure for Identifying Phloroglucinol-Terpenoid Inhibitors of SARS-CoV-2

G. Gao, Hao Song, J. Qi, 2022, Journal of natural products.

Neutralisation of ZF2001-elicited antisera to SARS-CoV-2 variants

G. Gao, Qihui Wang, A. Zheng, 2021, The Lancet Microbe.

Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2

G. Gao, J. Qi, Peiyi Wang, 2022, Cell.

Effects of a Prolonged Booster Interval on Neutralization of Omicron Variant

G. Gao, A. Zheng, Xinlei Zheng, 2022, The New England journal of medicine.

Neutralization of BQ.1, BQ.1.1, and XBB with RBD-Dimer Vaccines

G. Gao, Kun Xu, Dedong Li, 2023, The New England journal of medicine.

A protein subunit vaccine booster following two doses of inactivated SARS-CoV-2 vaccine provides high neutralisation of SARS-CoV-2 and its variants in mice

G. Gao, T. Luo, Kun Xu, 2021, The Lancet Microbe.

Neutralization of SARS-CoV-2 EG.5/EG.5.1 by sera from ZF2001 RBD-dimer and its next-generation vaccines

Kefang Liu, L. Dai, Kun Xu, 2023, bioRxiv.

Structural basis for receptor binding and broader interspecies receptor recognition of currently circulating Omicron sub-variants

Y. Chai, J. Qi, Peiyi Wang, 2023, Nature communications.

SARS-CoV-2 Omicron BA.2.86: less neutralization evasion compared to XBB sub-variants

Zepeng Xu, L. Dai, Kun Xu, 2023, bioRxiv.

Neutralization of EG.5, EG.5.1, BA.2.86, and JN.1 by antisera from dimeric receptor-binding domain subunit vaccines and 41 human monoclonal antibodies.

Linjie Li, Zepeng Xu, Kefang Liu, 2024, Med.

Molecular basis of hippopotamus ACE2 binding to SARS-CoV-2

S. Niu, Kefang Liu, Pu Han, 2024, Journal of virology.

Spike structures, receptor binding, and immune escape of recently circulating SARS-CoV-2 Omicron BA.2.86, JN.1, EG.5, EG.5.1, and HV.1 sub-variants.

Linjie Li, Zepeng Xu, Kefang Liu, 2024, Structure.